Genetic Analysis receives important patent allowance in China
OSLO, NORWAY - 14 October 2021: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has been awarded an important patent (CN107430644A) by the China National Intellectual Property Agency (CNIPA). The patent entitled “A METHOD FOR DETERMINING GASTROINTESTINAL TRACT DYSBIOSIS” covers the Company’s unique algorithm incorporated in the GA-map® technology for profiling gut microbiota. The positive decision from the Chinese patent authority means that the protection of the GA-map® technology has been substantially strengthened and will further support the